Laurent Knoops

JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis

Claire Harrison, Jean‐Jacques Kiladjian, Haifa Kathrin Al‐Ali et al. · New England Journal of Medicine · 2012 · 1.8K citations · Full text

Medicine, Hematology, Pharmacology +10

Three-year efficacy, safety, and survival findings from COMFORT-II, a phase 3 study comparing ruxolitinib with best available therapy for myelofibrosis

Francisco Cervantes, Alessandro M. Vannucchi, Jean‐Jacques Kiladjian et al. · Blood · 2013 · 425 citations · Full text

Medicine, Hematology, Pharmacology +4

Somatically acquired <i>JAK1</i> mutations in adult acute lymphoblastic leukemia

Elisabetta Flex, Valentina Petrangeli, Lorenzo Stella et al. · The Journal of Experimental Medicine · 2008 · 327 citations · Full text

Life Sciences, Genetics, Oncology +15

Gene-Expression and Immunohistochemical Study of Specific T-Cell Subsets and Accessory Cell Types in the Transformation and Prognosis of Follicular Lymphoma

Annuska M. Glas, Laurent Knoops, Leonie Delahaye et al. · Journal of Clinical Oncology · 2007 · 246 citations · Full text

Life Sciences, Immunology, Pathology +17

Transcription factor regulation can be accurately predicted from the presence of target gene signatures in microarray gene expression data

Ahmed Essaghir, Federica Toffalini, Laurent Knoops et al. · Nucleic Acids Research · 2010 · 212 citations · Full text

Life Sciences, Bioinformatics, Molecular Biology +17